Eckert & Ziegler Strahlen- und Medizintechnik AG provided earnings guidance for the year 2022. For the financial year 2022, the Management Board expects sales of around EUR 200 million and net income of around EUR 27 million. This forecast is subject to the assumption that developments in Ukraine do not result in any major disruptions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
46.5 EUR | -0.21% | +14.31% | +12.59% |
May. 15 | ECKERT & ZIEGLER : Hauck & Aufhauser reiterates its Buy rating | ZD |
May. 14 | Eckert & Ziegler SE Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.59% | 1.05B | |
+10.58% | 8.27B | |
-2.97% | 4.7B | |
+5.75% | 2.15B | |
-28.18% | 1.1B | |
-2.65% | 865M | |
-22.90% | 759M | |
-22.96% | 688M | |
-55.35% | 708M | |
-30.18% | 623M |
- Stock Market
- Equities
- EUZ Stock
- News Eckert & Ziegler SE
- Eckert & Ziegler Strahlen- und Medizintechnik AG Provides Earnings Guidance for the Year 2022